Shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Get Free Report) have been given a consensus recommendation of “Moderate Buy” by the twenty-two brokerages that are currently covering the stock, ...
Shares of Thermo Fisher Scientific Inc. TMO rose 1.81% to $532.02 Friday, on what proved to be an all-around favorable ...
A large pharmaceutical company collaborated with DelveInsight to evaluate CDMO companies for API and FD development. DelveInsight provided a comprehensive one-time report benchmarking top contract ...
An academic journal has retracted a study conducted by researchers with the science services giant Thermo Fisher Scientific ...
We recently published a list of the 12 Best Nanotechnology Stocks to Buy According to Hedge Funds. In this article, we are ...
Bioconjugation Market Bioconjugation Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The "Bioconjugation Market by Product ...
Thermo Fisher Scientific has launched the Applied Biosystems™ MagMAX™ Sequential DNA/RNA Kit, designed to help clinical and ...
Pharmaceutical Filtration Market Pharmaceutical Filtration Market Dublin, Jan. 02, 2025 (GLOBE NEWSWIRE) -- The ...
Evercore ISI analyst Vijay Kumar lowered the firm’s price target on Thermo Fisher (TMO) to $585 from $620 and keeps an Outperform rating on the ...
We recently published a list of 8 Best Low Volatility Stocks To Buy Right Now. In this article, we are going to take a look ...
Cell competition in epithelial tissue eliminates transformed cells expressing activated oncoproteins to maintain epithelial homeostasis. Although the process is now understood to be of mechanochemical ...